Navigation Links
Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams
Date:2/7/2008

CHAPEL HILL, N.C., Feb. 7 /PRNewswire/ -- Selecting and deploying cross- functional, yet sufficiently specialized, brand teams is a new challenge for marketing leaders at pharmas and biotechs. However, best-in-class pharma and biotech firms' brand teams share similar structure, composition, and responsibilities -- all detailed in a new benchmarking report by pharmaceutical research leader Best Practices, LLC.

According to research findings, most brands have a core team of three to 10 people and 86 percent of the pharma and biotech companies reported that the brand team leader sits in the marketing function.

The study, "Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management," yields insights into key benchmarks and strategies for designing effective brand teams. Managers and executives involved with brand teams can use this report to assess their teams and compare structure and governance styles of leading pharmaceutical and biotech brand teams.

A complimentary excerpt of the research report with sample key findings and metrics is reserved for you at http://www3.best-in-class.com/rr908.htm.

The study includes insights gleaned from survey results from brand team managers and executives representing 22 brands in 26 different companies. Deep-dive interviews to flesh out best practices were conducted with 10 managers from the benchmark partners, which included Abbott, Amylin, Bayer, Genentech, GSK, Roche, Novartis and Wyeth.
The comprehensive report reveals findings around key topics, including:

-- Staffing and functional representation for brand teams

-- Brand team operations, decision rights and responsibilities

-- Reporting relationships

-- Performance-based compensation and reviews

-- Brand performance measures

For a detailed report overview and sample metrics, download the report excerpt at http://www3.best-in-class.com/rr908.htm.

For questions or additional information on Best Practices, LLC's other products and services, please call Anna Buhr at 919-809-7560 or email abuhr@best-in-class.com.

If this study is not meeting your current business needs, inquire about starting your own research study or internet survey. Our custom client research will answer your pressing business questions and provide you with actionable insights and process best practices. Please contact Anna Buhr, Manager of Research Operations at abuhr@best-in-class.com to learn more about custom research in HR and other business fields.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
2. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
3. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
4. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
5. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
6. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
7. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
10. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
11. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... NY (PRWEB) , ... January 17, 2017 , ... ... Magazine’s fastest-growing private companies and ranked among the top US security companies for ... of Directors. This announcement brings a year-long independent board nomination process to ...
(Date:1/17/2017)... ... , ... Today, FloSports , a global leader in live digital sports ... of a long-term extension of their media partnership. The partnership, which began in 2013, ... sport’s premier events exclusively on FloWrestling.com as well as usage of the FloArena meet ...
(Date:1/16/2017)... ... January 17, 2017 , ... To provide ... recognized leader in the fast-casual category, announces a hearty and wholesome Winter Menu. ... Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky ...
(Date:1/16/2017)... , ... January 16, 2017 , ... California Southern University ... has served on CalSouthern’s Board of Trustees and as a core faculty member, teaching ... has been a professor of psychology at Pepperdine University, where he earned his Doctor ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT ... Las Vegas, Booth #2809. The SHOT Show is the shooting, hunting and outdoor ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... CHICAGO , Jan. 17, 2017 ... personalize cancer care, and University Hospitals Seidman Cancer ... healthcare by making genomic data, advanced molecular analysis ... hospital,s researchers, physicians and healthcare providers. ... will provide genomic and transcriptomic sequencing and analysis ...
(Date:1/17/2017)... , Jan. 17, 2017  ANI Pharmaceuticals, Inc. ... the appointment of Karen Quinn Ph.D as Vice ... Karen Quinn is ... experience in Global Regulatory Affairs, specifically with a ... ingredients.  Dr. Quinn worked most recently with Takeda ...
(Date:1/17/2017)... York , January 17, 2017 Transparency ... (Cinnamic Acid, Benzoic Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market ... According to the report, the global benzaldehyde derivative market ... to reach US$ 2.14 Bn by 2024, expanding at a CAGR ... ...
Breaking Medicine Technology: